Education
About Us
Working with TipRanks
Follow Us
Opus Genetics (IRD)
NASDAQ:IRD
0.75% Phentolamine Ophthalmic Solution
Vision Loss Night, Vision Disorders
Phase III
Recruiting
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity
Aug 22, 2025
―
Opgx-Best1
Arb, Bvmd, Autosomal-Dominant Bestrophinopathy, Best Vitelliform Macular Dystrophy
Phase I/II
Recruiting
Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)
Jul 17, 2025
―
0.75% Phentolamine Ophthalmic Solution
Presbyopia
Phase III
Active Not Recruiting
Evaluate Efficacy and Safety of POS to Improve Distance-corrected Near Visual in Participants With Presbyopia
Aug 05, 2024
―
Phentolamine Ophthalmic Solution 0.75%, A Non-Selective Alpha-1 And Alpha-2 Adrenergic Antagonist
Mesopic Vision, Night Vision Loss
Phase III
Active Not Recruiting
Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances
Apr 01, 2024
―
Phentolamine Opthalmic Solution 0.75%, Low Dose Pilocarpine, Low Dose Pilocarpine Vehicle
Presbyopia
Phase III
Completed
Safety and Efficacy of Nyxol Eye Drops as a Single Agent and With Adjunctive Low-Dose Pilocarpine Eye Drops in Subjects With Presbyopia
Dec 02, 2022
―
Aav8.Hlca5
Lca5
Phase I/II
Recruiting
Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD)
Nov 07, 2022
―
Phentolamine Ophthalmic Solution 0.75%, Pilocarpine
Presbyopia
Phase II
Completed
Safety and Efficacy of Nyxol With Pilocarpine Eye Drops in Subjects With Presbyopia
Dec 15, 2020
―
Phentolamine Ophthalmic Solution 0.75%
Dim Light Vision Disturbances
Phase III
Completed
Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) in Subjects With Dim Light Vision Disturbances
Nov 16, 2020
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Opus Genetics (IRD) have in its pipeline
IRD is currently developing the following drugs: 0.75% Phentolamine Ophthalmic Solution, Opgx-Best1, 0.75% Phentolamine Ophthalmic Solution. These drug candidates are in various stages of clinical development as the company works toward FDA approval.